This chart shows the pharmaceutical companies with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Finland? Read Post »
Annual Drug Patent Expirations for EMERPHED Emerphed is a drug marketed by Nexus Pharms and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Nexus Pharms drug EMERPHED appeared first on DrugP…
Annual Drug Patent Expirations for MEKINIST Mekinist is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent for Novartis drug MEKINIST appeared first on Drug…
Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on DrugPa…
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE appeared …
New patent for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fir…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Spain? Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent for Astrazeneca Ab drug BYDUREON appeared firs…
Annual Drug Patent Expirations for TRUSELTIQ Truseltiq is a drug marketed by Qed Therap and is included in one NDA. There are three patents protecting this drug. This drug has…
The post New patent for Qed Therap drug TRUSELTIQ appeared first on DrugPat…
Annual Drug Patent Expirations for OXLUMO Oxlumo is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are ten patents protecting this drug. This drug…
The post New patent for Alnylam Pharms drug OXLUMO appeared first on DrugPatent…
Get new actionable insights and updates from BiotechBlog
